Yasuo To

Targeting Phosphoinositide-3-Kinase-δ with Theophylline Reverses Corticosteroid Insensitivity in Chronic Obstructive Pulmonary Disease

Yasuo To, Kazuhiro Ito, Yasuo Kizawa et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 351 citations · Full text

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells

Christos Rossios, Yasuo To, Masako To et al. · European Journal of Pharmacology · 2011 · 86 citations

Asthma, Fluticasone Furoate, Inflammatory Lung Disease +7

Tacrolimus and Steroid Treatment for Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Nobuyuki Horita, Makiko Akahane, Yukinori Okada et al. · Internal Medicine · 2011 · 82 citations · Full text

Nortriptyline Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ

Nicolas Mercado, Yasuo To, Kazuhiro Ito et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 80 citations · Full text